Atlas FDA

VERSANT HCV Genotype 2.0 Assay (LiPA)

FDA premarket approval P160016/S005 · decided 2020-09-23

Approval details

PMA number
P160016
Supplement
S005
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
VERSANT HCV Genotype 2.0 Assay (LiPA)
Generic name
Assay, genotyping, hepatitis c virus
Applicant
Fujirebio Europe N.V.
Date received
2020-06-08
Decision date
2020-09-23
Days to decision
107 days
Decision code
APPR
Product code
OBF
Advisory committee
Microbiology
Expedited review
No
Location
Gent
Statement
Approval to replace the Triton X-705 detergent, a component of the 5X Rinse Solution and Conjugate Diluent used in the VERSANT HCV Genotyping 2.0 Assay, with the detergent Tergitol 15-S-40.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.